But for the 29 million Americans who currently take a semaglutide Ozempic or Wegovy or a terzapetide Mounjaro or Zepbound the results are mixed
Remedy Meds medication cost examples FDA Status of Compounded GLP-1 Medications As of June 2025, the FDA has removed both semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) from its drug shortage list
For employers, offering coverage for these drugs can support employees health journeys, potentially lowering long-term healthcare costs
Oxidative stress is a major factor that leads to cell aging
FDA review takes 1012 months, putting likely approval at late 2027 and US market launch at early-to-mid 2028
Designed for men and women looking for clean, everyday weight support as part of a healthy routine.